CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman’s Disease Phenotype in a Patient-Derived Kidney Organoid System
International Journal of Molecular Sciences · 03.02.2023 · 24 (3) · 3019
DOI: 10.3390/ijms24033019 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2023. Verfasst von Sun Woo Lim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Research Centre College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grants funded by the Korean government, National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
The aim of this study is to explore the possibility of modeling Gitelman’s disease (GIT) with human-induced pluripotent stem cell (hiPSC)-derived kidney organoids and to test whether gene correction using CRISPR/Cas9 can rescue the disease phenotype of GIT. To model GIT, we used the hiPSC line CMCi002 (CMC-GIT-001), generated using PBMCs from GIT patients with SLC12A3 gene mutation. Using the CRISPR-Cas9 system, we corrected CMC-GIT-001 mutations and hence generated CMC-GIT-001corr. Both hiPSCs were differentiated into kidney organoids, and we analyzed the GIT phenotype. The number of matured kidney organoids from the CMC-GIT-001corr group was significantly higher, 3.3-fold, than that of the CMC-GIT-001 group (12.2 ± 0.7/cm2 vs. 3.7 ± 0.2/cm2, p < 0.05). In qRT-PCR, performed using harvested kidney organoids, relative sodium chloride cotransporter (NCCT) mRNA levels (normalized to each iPSC) were increased in the CMC-GIT-001corr group compared with the CMC-GIT-001 group (4.1 ± 0.8 vs. 2.5 ± 0.2, p < 0.05). Consistently, immunoblot analysis revealed increased levels of NCCT protein, in addition to other tubular proteins markers, such as LTL and ECAD, in the CMC-GIT-001corr group compared to the CMC-GIT-001 group. Furthermore, we found that increased immunoreactivity of NCCT in the CMC-GIT-001corr group was colocalized with ECAD (a distal tubule marker) using confocal microscopy. Kidney organoids from GIT patient-derived iPSC recapitulated the Gitelman’s disease phenotype, and correction of SLC12A3 mutation utilizing CRISPR-Cas9 technology provided therapeutic insight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transplantation Research Centre College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Internal Medicine, Division of Nephrology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- R&D Center, ToolGen, Inc., Seoul 06591, Republic of Korea.
ORCID-Profile: Sun Woo Lim, Sheng Cui, Chul Woo Yang
Förderung
- National Research Foundation of Korea (NRF) grants funded by the Korean government
- National Research Foundation of Korea (NRF)
Zitieren
APA
Lim, S. W., Fang, X., Cui, S., Lee, H., Shin, Y. J., Ko, E. J., Lee, K. I., Lee, J. Y., Chung, B. H., & Yang, C. W. (2023). CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman’s Disease Phenotype in a Patient-Derived Kidney Organoid System. International Journal of Molecular Sciences, 24(3), 3019. https://doi.org/10.3390/ijms24033019
Vancouver
Lim SW, Fang X, Cui S, Lee H, Shin YJ, Ko EJ, et al. CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman’s Disease Phenotype in a Patient-Derived Kidney Organoid System. International Journal of Molecular Sciences. 2023;24(3):3019. doi:10.3390/ijms24033019
BibTeX
@article{Lim2023,
author = {Lim, Sun Woo and Fang, Xianying and Cui, Sheng and Lee, Hanbi and Shin, Yoo Jin and Ko, Eun Jeong and Lee, Kang In and Lee, Jae Young and Chung, Byung Ha and Yang, Chul Woo},
title = {CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman’s Disease Phenotype in a Patient-Derived Kidney Organoid System},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {3019},
doi = {10.3390/ijms24033019}
}
EUVIMED